Teladoc Health Target of Unusually Large Options Trading (NYSE:TDOC)

Teladoc Health, Inc. (NYSE:TDOC) was the target of some unusual options trading on Tuesday. Stock investors purchased 22,980 call options on the stock. This represents an increase of 69% compared to the typical volume of 13,593 call options.

Analyst Upgrades and Downgrades

TDOC has been the topic of several research analyst reports. Piper Sandler reaffirmed an “overweight” rating and issued a $13.00 price objective (up from $11.00) on shares of Teladoc Health in a research note on Wednesday, December 4th. TD Cowen dropped their price target on shares of Teladoc Health from $9.00 to $8.00 and set a “hold” rating on the stock in a research report on Thursday, October 31st. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Teladoc Health from $10.00 to $12.00 and gave the stock a “hold” rating in a research report on Friday, November 1st. Jefferies Financial Group upped their price objective on shares of Teladoc Health from $8.00 to $10.00 and gave the stock a “hold” rating in a report on Tuesday, September 17th. Finally, Royal Bank of Canada lifted their target price on Teladoc Health from $9.00 to $10.00 and gave the company an “outperform” rating in a research report on Wednesday, October 9th. Fourteen research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, Teladoc Health currently has an average rating of “Hold” and a consensus price target of $12.24.

Teladoc Health Stock Up 0.5 %

Shares of NYSE TDOC opened at $9.98 on Wednesday. Teladoc Health has a 52 week low of $6.76 and a 52 week high of $22.16. The company has a market cap of $1.72 billion, a P/E ratio of -1.73 and a beta of 1.01. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The business has a 50-day simple moving average of $9.92 and a two-hundred day simple moving average of $9.03.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share for the quarter, beating the consensus estimate of ($0.29) by $0.10. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The firm had revenue of $640.51 million for the quarter, compared to analysts’ expectations of $630.50 million. Research analysts anticipate that Teladoc Health will post -1.16 earnings per share for the current fiscal year.

Insider Activity at Teladoc Health

In other news, insider Carlos Nueno sold 2,389 shares of the company’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $11.93, for a total transaction of $28,500.77. Following the completion of the sale, the insider now owns 2,890 shares of the company’s stock, valued at approximately $34,477.70. This represents a 45.25 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 0.95% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Versant Capital Management Inc lifted its position in Teladoc Health by 313.8% in the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock valued at $29,000 after purchasing an additional 2,441 shares during the last quarter. Blue Trust Inc. raised its holdings in shares of Teladoc Health by 84.5% during the third quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider’s stock valued at $40,000 after acquiring an additional 1,854 shares in the last quarter. Doheny Asset Management CA purchased a new stake in Teladoc Health in the second quarter worth $46,000. Benjamin F. Edwards & Company Inc. lifted its stake in Teladoc Health by 209.8% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 5,015 shares of the health services provider’s stock worth $49,000 after acquiring an additional 3,396 shares during the period. Finally, Point72 Asia Singapore Pte. Ltd. boosted its holdings in Teladoc Health by 194.2% in the second quarter. Point72 Asia Singapore Pte. Ltd. now owns 6,891 shares of the health services provider’s stock valued at $67,000 after acquiring an additional 4,549 shares in the last quarter. 76.82% of the stock is currently owned by institutional investors.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.